Torthaí cuardaigh - Geert D’Haens
- 1 - 20 toradh as 228 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Risks and benefits of biologic therapy for inflammatory bowel diseases de réir Geert D’Haens
Foilsithe / Cruthaithe 2007Revisão -
2
Systematic review: second‐generation vs. conventional corticosteroids for induction of remission in ulcerative colitis de réir Geert D’Haens
Foilsithe / Cruthaithe 2016Revisão -
3
Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection de réir Geert D’Haens, Christian Jobin
Foilsithe / Cruthaithe 2019Revisão -
4
Anti-interleukin-23 agents for the treatment of ulcerative colitis de réir Jurij Hanžel, Geert D’Haens
Foilsithe / Cruthaithe 2019Revisão -
5
Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease de réir Anne S. Strik, Steven Bots, Geert D’Haens, Mark Löwenberg
Foilsithe / Cruthaithe 2015Revisão -
6
Emerging therapies for ulcerative colitis de réir Jurij Hanžel, Melanie S. Hulshoff, Joep Grootjans, Geert D’Haens
Foilsithe / Cruthaithe 2022Revisão -
7
Combination Immunosuppression in IBD de réir Steven Bots, K Gecse, Murray L. Barclay, Geert D’Haens
Foilsithe / Cruthaithe 2018Revisão -
8
The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms de réir Sofía Frigerio, Dalia A. Lartey, Geert D’Haens, Joep Grootjans
Foilsithe / Cruthaithe 2021Revisão -
9
Appendectomy protects against ulcerative colitis de réir Paul Rutgeerts, Geert D’Haens, Martin Hiele, Karel Geboes, Gaston Vantrappen
Foilsithe / Cruthaithe 1994Artigo -
10
Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease de réir Geert D’Haens, Karel Geboes, Eric Ponette, F Penninckx, P. Rutgeerts
Foilsithe / Cruthaithe 1997Artigo -
11
Clinical guidelines for the management of pouchitis de réir Darrell S. Pardi, Geert D’Haens, Bo Shen, Simon Campbell, Paolo Gionchetti
Foilsithe / Cruthaithe 2009Artigo -
12
Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound Index de réir Steven Bots, Kim Nylund, Mark Löwenberg, K Gecse, Geert D’Haens
Foilsithe / Cruthaithe 2021Artigo -
13
Future directions in inflammatory bowel disease management de réir Geert D’Haens, R. Balfour Sartor, Mark S. Silverberg, Joel Petersson, Paul Rutgeerts
Foilsithe / Cruthaithe 2014Revisão -
14
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum de réir Geert D’Haens, Karel Geboes, Marc Peeters, Filip Baert, Freddy Penninckx, P. Rutgeerts
Foilsithe / Cruthaithe 1998Artigo -
15
-
16
Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review de réir Jean‐Frédéric Colombel, Geert D’Haens, Wan‐Ju Lee, Joel Petersson, Remo Panaccione
Foilsithe / Cruthaithe 2019Revisão -
17
-
18
Assessment of mucosal healing in inflammatory bowel disease: review de réir Parambir S. Dulai, Barrett G. Levesque, Brian G. Feagan, Geert D’Haens, William J. Sandborn
Foilsithe / Cruthaithe 2015Revisão -
19
The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease de réir Leonie C.S. De Vries, Manon E. Wildenberg, Wouter J. de Jonge, Geert D’Haens
Foilsithe / Cruthaithe 2017Revisão -
20
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis de réir Sophie E. Berends, Anne S. Strik, Mark Löwenberg, Geert D’Haens, Ron A. A. Mathôt
Foilsithe / Cruthaithe 2018Revisão
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Disease
Gastroenterology
Crohn's disease
Ulcerative colitis
Inflammatory bowel disease
Surgery
Pathology
Randomized controlled trial
Infliximab
Alternative medicine
Clinical trial
Placebo
Immunology
Tumor necrosis factor alpha
Adverse effect
Physics
Adalimumab
Clinical endpoint
Intensive care medicine
Biology
Chemotherapy
Confidence interval
Cohort
Colitis
Cancer
Colorectal cancer
Maintenance therapy
Radiology